Canada markets closed

Mesoblast Limited (MEOBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.73890.0000 (0.00%)
At close: 03:30PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 453.69M
Enterprise Value 498.25M
Trailing P/E N/A
Forward P/E 769.23
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)65.91
Price/Book (mrq)1.09
Enterprise Value/Revenue 65.07
Enterprise Value/EBITDA -8.06

Trading Information

Stock Price History

Beta (5Y Monthly) 2.55
52-Week Change 3-13.95%
S&P500 52-Week Change 3-14.12%
52 Week High 30.8600
52 Week Low 30.4400
50-Day Moving Average 30.6176
200-Day Moving Average 30.5819

Share Statistics

Avg Vol (3 month) 3131
Avg Vol (10 day) 3N/A
Shares Outstanding 5736.58M
Implied Shares Outstanding 6N/A
Float 8653.51M
% Held by Insiders 112.24%
% Held by Institutions 123.75%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-952.76%

Management Effectiveness

Return on Assets (ttm)-6.83%
Return on Equity (ttm)-16.25%

Income Statement

Revenue (ttm)7.87M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-10.40%
Gross Profit (ttm)-53.36M
EBITDA -72.36M
Net Income Avi to Common (ttm)-84.13M
Diluted EPS (ttm)-0.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.62M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)111.78M
Total Debt/Equity (mrq)22.36
Current Ratio (mrq)1.43
Book Value Per Share (mrq)0.68

Cash Flow Statement

Operating Cash Flow (ttm)-60.1M
Levered Free Cash Flow (ttm)-50.49M